Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cellectar Biosc (CLRB)

Cellectar Biosc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,641
  • Shares Outstanding, K 35,849
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,980 K
  • 60-Month Beta 0.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.40
Trade CLRB with:

Options Overview Details

View History
  • Implied Volatility 89.17% ( -2.82%)
  • Historical Volatility 35.31%
  • IV Percentile 22%
  • IV Rank 25.07%
  • IV High 280.87% on 03/15/24
  • IV Low 25.03% on 08/22/24
  • Put/Call Vol Ratio 0.05
  • Today's Volume 192
  • Volume Avg (30-Day) 76
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 3,182
  • Open Int (30-Day) 2,750

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.23
  • Number of Estimates 1
  • High Estimate -0.23
  • Low Estimate -0.23
  • Prior Year -0.73
  • Growth Rate Est. (year over year) +68.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.96 +7.14%
on 08/19/24
2.29 -8.30%
on 08/30/24
+0.07 (+3.45%)
since 08/16/24
3-Month
1.82 +15.38%
on 08/05/24
3.15 -33.33%
on 07/22/24
-0.57 (-21.35%)
since 06/18/24
52-Week
1.82 +15.38%
on 08/05/24
4.45 -52.81%
on 03/04/24
-0.02 (-0.94%)
since 09/18/23

Most Recent Stories

More News
Cellectar Reports Financial Results for Second Quarter 2022

FLORHAM PARK, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the...

CLRB : 2.10 (-0.47%)
Cellectar Announces Stock Consolidation

FLORHAM PARK, N.J., July 21, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage biopharmaceutical company focused on the...

CLRB : 2.10 (-0.47%)
Cellectar Reports Financial Results for First Quarter 2022 and Provides a Corporate Update

FLORHAM PARK, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...

CLRB : 2.10 (-0.47%)
Cellectar Biosciences Announces Key Commercial Team Appointments

Matthew Hagan Appointed Vice President, Marketing and Strategic Alliances David Lasecki Appointed Executive Director, Strategic Alliances FLORHAM PARK,...

CLRB : 2.10 (-0.47%)
Cellectar Reports Financial Results for Year Ended December 2021 and Provides a Corporate Update

FLORHAM PARK, N.J., March 21, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company...

CLRB : 2.10 (-0.47%)
Cellectar to Participate at Upcoming Banking Conferences

FLORHAM PARK, N.J., March 10, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company...

CLRB : 2.10 (-0.47%)
Cellectar to Participate in Fireside Chat at the H.C. Wainwright Bioconnect Conference

FLORHAM PARK, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...

CLRB : 2.10 (-0.47%)
Cellectar Presented Data from its Ongoing Phase 2 CLOVER-1 Study of Iopofosine I-131 at the 63rd ASH Annual Meeting and Exposition

Poster highlighted data from 11 patients with at least triple class refractory multiple myeloma Mean ORR of 45.5%, CBR of 72.7% and DCR of 100% and the...

CLRB : 2.10 (-0.47%)
Cellectar Biosciences Announces Poster Presentation at the 63rd American Society for Hematology Annual Meeting and Exposition

FLORHAM PARK, N.J., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...

CLRB : 2.10 (-0.47%)
Cellectar’s Iopofosine I-131 Exhibits Signals of Efficacy in Phase I Study for Pediatric Brain and Solid Tumors

FLORHAM PARK, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...

CLRB : 2.10 (-0.47%)

Business Summary

Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in...

See More

Key Turning Points

3rd Resistance Point 2.30
2nd Resistance Point 2.25
1st Resistance Point 2.18
Last Price 2.10
1st Support Level 2.06
2nd Support Level 2.01
3rd Support Level 1.94

See More

52-Week High 4.45
Fibonacci 61.8% 3.45
Fibonacci 50% 3.13
Fibonacci 38.2% 2.82
Last Price 2.10
52-Week Low 1.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar